Standard Biotools | FLDM - Gross Profit On Sales


Standard Biotools reported $11.31M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Agilent USD 990M 44M Mar/2026
Becton, Dickinson and Co. USD 2.15B 257M Mar/2026
Bio-Rad Laboratories USD 345.2M 1.8M Dec/2025
Bruker USD 379.8M 69.4M Mar/2026
Danaher USD 3.59B 375M Mar/2026
Illumina USD 721M 38M Mar/2026
Myriad Genetics USD 146.8M 3M Dec/2025
Nikon Corporation JPY 67.21B 14.78B Jun/2025
Pacific Biosciences Of California USD 15.74M 601K Dec/2025
Revvity USD 387.66M 34M Mar/2026
Roche Holding CHF 22.09B 10.04B Dec/2025
Sony JPY 934.27B 121.78B Mar/2026
Standard Biotools USD 11.31M 74K Mar/2026
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Waters USD 542M 15.42M Mar/2026